Latest Research

O J Kennedy at al, 2021. All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study, BMC Public Health, Volume 21 Article 970.

J Chhimwal et al, 2021. Beverages and Non-alcoholic fatty liver disease (NAFLD): Think before you drink, Clinical Nutrition, Volume 40 (1).

C Lammert et al, 2021. Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption, Dig Dis Sci, published online.

I Mikolasevic et al, Relationship between coffee consumption, sleep duration and smoking status with elastographic parameters of liver steatosis and fibrosis: controlled attenuation parameter and liver stiffness measurements, International Journal of Clinical Practice, published online.

J B Whitfield et al, 2020. Obesity, diabetes, coffee, tea, and cannabis use alter risk for alcohol related cirrhosis in 2 large cohorts of high risk drinkers, American Journal of Gastroenterology, published online.

Y Zhang et al, 2020. Habitual coffee intake and risk for non-alcoholic fatty liver disease: a two-sample Mendelian randomization study, European Journal of Nutrition, published online

X Zhang et al, 2020. Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease, Liver International, published online.

H K Chung et al, 2020. The increased amount of coffee consumption lowers the incidence of fatty liver disease in Korean men, Nutrition, Metabolism and Cardiovascular Disease, published online.

J Ding & Y Zhang, 2020. Association of Coffee Consumption With the Circulating Levels of Alanine Aminotransferase and Aspartate Aminotransferase. A Meta-Analysis of Observational Studies, Journal of the American College of Nutrition, published online.

U Nivukoski et al, 2020. Combined effects of lifestyle risk factors for fatty liver index. BMC Gastroenterology, Volume 20 (1).

This information is intended for Healthcare professional audiences.
Please consider the environment before printing.